Chlorine in PDB, part 348 (files: 13881-13920),
PDB 5qca-5qhu
Experimental structures of coordination spheres of Chlorine (Cl) in bioorganic
molecules from X-Ray and NMR experiments. Coordination spheres were calculated with 5.0 Angstroms radius
around Chlorine atoms. PDB files: 13881-13920 (PDB 5qca-5qhu).
-
5qca (Cl: 4) - Crystal Structure of Human Cathepsin-S with Bound Ligand
-
5qcc (Cl: 2) - Crystal Structure of Human Cathepsin-S with Bound Ligand
Other atoms:
I (2);
-
5qcd (Cl: 1) - Crystal Structure of Human Cathepsin-S with Bound Ligand
-
5qce (Cl: 4) - Crystal Structure of Human Cathepsin-S with Bound Ligand
-
5qcf (Cl: 2) - Crystal Structure of Human Cathepsin-S with Bound Ligand
-
5qcg (Cl: 4) - Crystal Structure of Human Cathepsin-S with Bound Ligand
-
5qch (Cl: 8) - Crystal Structure of Human Cathepsin-S with Bound Ligand
-
5qci (Cl: 1) - Crystal Structure of Human Cathepsin-S with Bound Ligand
-
5qck (Cl: 1) - Factor Xia in Complex with the Inhibitor 4-[[(2~{S},3~{R})-1-[(~{E})- 3-[5-Chloranyl-2-(1,2,3,4-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl]-3- Phenyl-Pyrrolidin-2-Yl]Carbonylamino]Benzoic Acid
-
5qcl (Cl: 1) - Factor Xia in Complex with the Inhibitor 4-[[(1~{S})-2-[(~{E})-3-[5- Chloranyl-2-(1,2,3,4-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl]-3,4-Dihydro- 1~{H}-Isoquinolin-1-Yl]Carbonylamino]Benzoic Acid
-
5qcm (Cl: 1) - Factor Xia in Complex with the Inhibitor Methyl ~{N}-[4-[[(1~{S})-2- [(~{E})-3-[3-Chloranyl-2-Fluoranyl-6-(1,2,3,4-Tetrazol-1-Yl) Phenyl]Prop-2-Enoyl]-3,4-Dihydro-1~{H}-Isoquinolin-1- Yl]Carbonylamino]Phenyl]Carbamate
Other atoms:
F (1);
-
5qcn (Cl: 1) - Factor Xia in Complex with the Inhibitor 4-[[(1~{S})-2-[(~{E})-3-[5- Chloranyl-2-(1,2,3,4-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl]-5-[(3~{S})-3- Ethoxycarbonylpiperidin-1-Yl]Carbonyl-3,4-Dihydro-1~{H}-Isoquinolin- 1-Yl]Carbonylamino]Benzoic Acid
-
5qd5 (Cl: 3) - Crystal Structure of Bace Complex with BMC009
-
5qdh (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMOPL000004A
-
5qe6 (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMOPL000608A
-
5qe9 (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMOPL000232A
-
5qeb (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMOPL000639A
-
5qed (Cl: 6) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMOPL000538A
-
5qej (Cl: 4) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMSOA001247B
-
5qes (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMOMB000141A
-
5qeu (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMOMB000149A
-
5qev (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_XST00000603B
-
5qew (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMSOA000470B
-
5qf2 (Cl: 4) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMOMB000187A
-
5qf7 (Cl: 4) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMSOA000951B
-
5qfa (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_XST00000752B
-
5qfj (Cl: 4) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMSOA000814B
-
5qfn (Cl: 6) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMOPL000324A
-
5qfz (Cl: 4) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMOPL000711A
-
5qgf (Cl: 4) - Pandda Analysis Group Deposition -- Crystal Structure of PTP1B in Complex with COMPOUND_FMOOA000539A
-
5qgs (Cl: 1) - Pandda Analysis Group Deposition of Models with Modelled Events (E.G. Bound Ligands) -- Crystal Structure of NUDT7 in Complex with FMOPL000476A
-
5qgv (Cl: 1) - Pandda Analysis Group Deposition of Models with Modelled Events (E.G. Bound Ligands) -- Crystal Structure of NUDT7 in Complex with UNUYB062989
-
5qgx (Cl: 1) - Pandda Analysis Group Deposition of Models with Modelled Events (E.G. Bound Ligands) -- Crystal Structure of NUDT7 in Complex with NUOOA000155
-
5qgy (Cl: 1) - Pandda Analysis Group Deposition of Models with Modelled Events (E.G. Bound Ligands) -- Crystal Structure of NUDT7 in Complex with NUOOA000158
-
5qgz (Cl: 1) - Pandda Analysis Group Deposition of Models with Modelled Events (E.G. Bound Ligands) -- Crystal Structure of NUDT7 in Complex with NUOOA000161
Other atoms:
F (1);
-
5qh1 (Cl: 1) - Pandda Analysis Group Deposition of Models with Modelled Events (E.G. Bound Ligands) -- Crystal Structure of NUDT7 in Complex with NUOOA000181
-
5qhg (Cl: 1) - Pandda Analysis Group Deposition of Models with Modelled Events (E.G. Bound Ligands) -- Crystal Structure of NUDT7 in Complex with NU000442A
-
5qhh (Cl: 1) - Pandda Analysis Group Deposition of Models with Modelled Events (E.G. Bound Ligands) -- Crystal Structure of NUDT7 in Complex with NU000443A
-
5qht (Cl: 2) - Pandda Analysis Group Deposition -- Crystal Structure of Human PARP14 Macrodomain 3 in Complex with FMOPL000065A
-
5qhu (Cl: 2) - Pandda Analysis Group Deposition of Models with Modelled Events (E.G. Bound Ligands) -- Crystal Structure of Human PARP14 Macrodomain 3 in Complex with FMSOA000341B
Page generated: Sun Dec 15 10:03:55 2024
|
